Aegros is pleased to share this update on our operations, planning and strategies with investors. This update was filmed in conjunction with STK Markets and includes the latest information on Aegros’ activities, delivered by Founders, Professor Hari Nair and John Manusu.
Information in this update includes:
1. Clinical Trials update
2. F(actory) A(cceptance) T(est) in Barcelona
3. Scalability Testing update
4. Signed Agreement for supply of 100k litres of blood plasma pa for 3 years
5. Heads of Agreement for Land in Brisbane
6. USA markets update
7. Released product for the rest of clinical trials
8. Aegros sponsorship of Qld University ‘scale-up’ workshop
9. Manuscript on Peer Review (Scientific and Medical validation)
10. Interest from overseas (re: treatment by hyperimmune)
11. Key Aegros Milestones between now and IPO
12. Sydney facility upgrade.
The next update will be in mid-July.